The acute myocardial infarction: A review of diagnosis and treatment;Der akute myokardinfarkt: Eine übersicht über diagnostik und therapie

Medizinische Monatsschrift fur Pharmazeuten

Volumn 34, Issue 3, 2011, Pages

  Radke, Peter W ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; CARDIOVASCULAR SYSTEM EXAMINATION; REVIEW; DRUG ANTAGONISM; DRUG EFFECT; ELECTROCARDIOGRAPHY; EMERGENCY HEALTH SERVICE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; PRACTICE GUIDELINE; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR; FIBRINOLYTIC AGENT; P2RY12 PROTEIN, HUMAN; PURINERGIC P2Y12 RECEPTOR;

ANGINA, UNSTABLE; ANGIOPLASTY, BALLOON, CORONARY; ANTICOAGULANTS; ASPIRIN; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; EMERGENCY SERVICE, HOSPITAL; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PRACTICE GUIDELINES AS TOPIC; RECEPTORS, PURINERGIC P2Y12; RISK FACTORS; THROMBOLYTIC THERAPY;

EID: 79953659195     PISSN: 03429601     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
2. Cannon CP, Harrington RA, James S, Ardissino D, et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet 2010;375:283-93.
3. De Luca G, Suryapranata H, Stone GW, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 2005;293:1759-65.
4. Geeganage C, Wilcox R, Bath PMW. Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis. BMC Med 2010;8:36 (doi:10.1186/1741-7015-8-36).
5. Hamm CW. Kommentar zu den Leitlinien der European Society of Cardiology (ESC) zur Diagnose und Therapie des akuten Koronarsyndroms ohne ST-Strecken-Hebung (NSTE-ACS). Der Kardiologe 2009;3:81-100 (DOI:10.1007/s12181- 009-0177-2).
6. Mehilli J, Kastrati A, Schulz S, Früngel S, et al. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation 2009;119:1933-40.
7. Mehran R, Lansky AJ, Witzenbichler B, Guagliumi G, et al. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 2009;374(9696):1149-59.
8. Montalescot G, Wiviott SD, Braunwald E, Murphy SA, et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 2009;373:723-31.
9. Radke PW, Schunkert H. Diabetics with acute coronary syndrome: advances, challenges, and uncertainities. Eur Heart J 2010;31:2971-3.
10. Rudez G, Bouman HJ, van Werkum JW, Leebeek FW. Common variation in the platelet receptor P2RY12 gene is associated with residual on-clopidogrel platelet reactivity in patients undergoing elective percutaneous coronary interventions. Circ Cardiovasc Genet 2009;5:515-21.
11. Saia F, Marrozzini C, Ortolani P, Palmerini T, et al. Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality. Heart 2009;95:370-6.
12. Scholz KH, von Knobelsdorff G, Ahlersmann D, Keating FK. Prozessentwicklung in der Herzinfarktversorgung Netzwerkbildung, Telemetrie und standardisiertes Qualitätsmanagement mit systematischer Ergebnisrückkopplung. Herz 2008;33:102-9.
13. Silber S, Borggrefe M, Hasenfuß G, Falk V, et al. Kommentare zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Therapie von Patienten mit ST-Streckenhebungsinfarkt (STEMI). Der Kardiologe 2010;4:84-92 (doi 10.1007/s12181-009-0246-6).
14. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-30. (Pubitemid 351724451)
15. Task Force for diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of European Society of Cardiology, Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-660.
16. The CURRENT-OASIS 7 Investigators, Mehta SR, Bassand JP, Chrolavicius S, et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med 2010;363:930-42.
17. Thews G (Begr.), Mutschler E., Vaupel P, Schaible H-G. Anatomie, Physiologie, Pathophysiologie des Menschen. 6. Auflage. Stuttgart: Wissenschaftliche Verlagsgesellschaft Stuttgart, 2007.
18. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-45.